Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 51,701,197 $ 139,220,208
Marketable securities 141,619,768 39,543,820
Prepaid research and development 3,998,159 1,001,993
Prepaid expenses and other current assets 1,412,941 343,374
Total current assets 198,732,065 180,109,395
Prepaid research and development, noncurrent 2,780,307 1,000,000
Other assets 239,577 95,121
Total assets 201,751,949 181,204,516
Current liabilities:    
Accounts payable 947,993 1,158,054
Accrued expenses and other current liabilities (see Note 6) 12,008,758 4,081,282
Contingent consideration liability 0 3,061,501
Total current liabilities 12,956,751 8,300,837
Total liabilities 12,956,751 8,300,837
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value; 500,000,000 shares authorized; 132,032,636 and 131,691,237 shares issued and outstanding (including 0 and 4,149,252 contingently issuable shares - see Note 10) at June 30, 2026 and December 31, 2025, respectively 140,270 131,691
Additional paid-in capital 387,883,494 315,429,986
Accumulated other comprehensive (loss) income (109,361) 21,802
Accumulated deficit (199,119,205) (142,679,800)
Total stockholders' equity 188,795,198 172,903,679
Total liabilities and stockholders' equity $ 201,751,949 $ 181,204,516